Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2/3 2Phase NA 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Vomiting 2Carcinoma, Non-Small-Cell Lung 2Somatoform Disorders 1Neoplasms 1Nausea 1Multiple Myeloma 1Lymphoma 1Hematologic Neoplasms 1Delirium 1Breast Neoplasms 1

Interventions

Pemetrexed 10Cisplatin 9Erlotinib Hydrochloride 8Carboplatin 7icotinib 5Gefitinib 5Docetaxel 5endostar protein 3Zoledronic Acid 3Radiotherapy 3Paclitaxel 3Gemcitabine 3Endostatins 3Afatinib 3tislelizumab 2pembrolizumab 2osimertinib 2lorlatinib 2flurbiprofen axetil 2dexamethasone 21-phosphate 2atezolizumab 2Vinorelbine 2Surgical Procedures, Operative 2Saline Solution 2Nivolumab 2Drug Therapy 2Dexamethasone 2Chemoradiotherapy 2trametinib 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Non-Small-Cell Lung × dexamethasone 21-phosphate × Clear all
NCT03200600 2021-07-13

Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery

Peking University First Hospital

Phase 4 Terminated
126 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Delirium

NCT03172988 2019-03-05

Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery

Peking University First Hospital

Phase 4 Terminated
126 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡